Detalhe da pesquisa
1.
CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia.
Acta Pharmacol Sin
; 43(1): 121-132, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33767379
2.
Author Correction: CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia.
Acta Pharmacol Sin
; 43(7): 1884, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35087232